$HIMS News

What Bears Saw Before Hims & Hers Health Slid

Hims & Hers Health (HIMS) Debuts Injectable And Oral Testosterone Therapies

Hims & Hers Health, Inc. (HIMS) Declines More Than Market: Some Information for Investors

Market Chatter: Hims & Hers Health Bids Judge to Toss Federal Trade Commission Complaint

Hims & Hers Stock Has Barely Moved Since Its Biggest Men’s Health Launch. Here’s What November 9 Has to Show

Telehealth Firm Hims & Hers Seeks Dismissal Of FTC Privacy And Subscription Lawsuit

'Hims Seeks Dismissal of FTC Suit Over User Data, Subscriptions' - Bloomberg News

Hims Expands Testosterone Care with Injectable and Oral TRT, Its Largest Men’s Health Launch to Date

Hims & Hers Gains as It Launches Men’s Weight-Loss Care in Germany

HIMS Stock Gains As Company Enters German Men’s Weight Market As Investors Watch US Peptide Compounding Policy

Hims & Hers Health Announces Launch Of Hims In Germany

Hims & Hers Health: The Lollapalooza Effect Of GLP-1s

Hims & Hers Health (HIMS) Dropped, So What Is Driving Attention Now?

Peptide Rule Change Could Matter For Hims Shares (HIMS)

Hims And Hers Health (HIMS) Stock May Trade At A Discount Despite Australia Launch

What Does Hims & Hers Health (HIMS) Expansion Into The UK And Australia Mean?

Hims & Hers Health, Inc. (HIMS) is Attracting Investor Attention: Here is What You Should Know

HIMS Stock Snaps 3-Day Slump On Peptide Hopes: Trump Administration Reviews Plan That Could Unlock $2.2B Market

Hims & Hers Health, Inc. (HIMS) Suffers a Larger Drop Than the General Market: Key Insights

Hims & Hers Expands Australian Women's Health Platform With Hers